The Ozempic manufacturer, represented in both cases by Fenwick & West, filed one complaint on Wednesday in the District of Delaware, then filed a nearly identical one in the Northern District of West Virginia.
July 03, 2024 at 04:32 PM
2 minute read
Novo Nordisk has filed two patent infringement suits in federal court seeking to block Mylan from developing a generic form of Ozempic.
The Ozempic manufacturer, represented in both cases by Fenwick & West, filed one complaint on Wednesday in the District of Delaware, then filed a nearly identical one in the Northern District of West Virginia.
Presented by BigVoodoo
The National Law Journal Elite Trial Lawyers recognizes U.S.-based law firms performing exemplary work on behalf of plaintiffs.
GlobeSt. Women of Influence Conference celebrates the women who drive the commercial real estate industry forward.
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
Cullen and Dykman is seeking an associate attorney with a minimum of 5+ years in insurance coverage experience as well as risk transfer and ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
Ozempic semaglutide injection pens. Credit: mbruxelle/Adobe Stock
